At launch, the LEX system will report positive results in as little as 5-minutes with multiplex testing for the detection and differentiation of Flu A, Flu B and COVID-19, while negative results will report in under 10 minutes. The system is designed for use in CLIA waived settings with a fully automated swab-to-result workflow that requires no liquid sample handling, saving hands on time and reducing the risk of infection. The compact footprint is intended for use at the point of care in a physician’s office, pharmacy or urgent care facility.

LEX plans to expand respiratory test offering by developing RSV and Strep B tests which we expect will operate faster and run to completion in approximately 5 minutes. When we develop our second generation instrument, we plan to introduce Sexual Transmitted Infection (STI) testing to our portfolio of tests.